FDA adds precautionary warning for Tamiflu

11/14/2006 | Washington Post (tiered subscription model), The

The agency announced an updated label for the flu drug, saying those taking Tamiflu should be closely monitored for abnormal behavior. The FDA says it has received more than 100 reports of injury and delirium associated with children taking the Roche Holding drug, most of them coming from Japan. A Roche spokesman says there was no evidence the drug caused the side effects.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ